Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
MDS/AML
Description:
A hematologic disease category spanning myelodysplastic syndromes and acute myeloid leukemia, used in classification and risk assessment.
Primary topic:
Acute Myeloid Leukemia Research (74%)
Related topics:
Acute Myeloid Leukemia Research (74%),
Hematopoietic Stem Cell Transplantation (13%)
OpenAlex ID:
keywords/mds-aml
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
2008
·
Naoko Watanabe-Okochi
, Jiro Kitaura
, et al.
·
Blood
·
164
‘Low‐risk’ myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐ versus anti‐apoptotic bcl‐2‐related proteins
1998
·
Parker
, Fishlock
, et al.
·
British Journal of Haematology
·
129
The International Consensus Classification of acute myeloid leukemia
2022
·
Olga K. Weinberg
, Anna Porwit
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
100
Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations
2009
·
Yuka Harada
, Hironori Harada
·
Journal of Cellular Physiology
·
97
Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations
2006
·
H Niimi
, H Harada
, et al.
·
Leukemia
·
75
E2197: Phase III AT (doxorubicin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer
2005
·
L. J. Goldstein
, A. O’Neill
, et al.
·
Journal of Clinical Oncology
·
68
Long-term safety and secondary efficacy endpoints in the ENGOT-OV16/NOVA phase III trial of niraparib in recurrent ovarian cancer
2021
·
Ursula Matulonis
, Jørn Herrstedt
, et al.
·
Gynecologic Oncology
·
66
Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes
2006
·
Rosimeire A. Roela
, Dirce M. Carraro
, et al.
·
Leukemia Research
·
36
MDS subclassification—do we still have to count blasts?
2023
·
Sandra Huber
, Torsten Haferlach
, et al.
·
Leukemia
·
32
PDF
Biologic characteristics of acute leukemia after myelodysplastic syndrome
1993
·
M Masuya
, K Kita
, et al.
·
Blood
·
30
Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome
2013
·
Victoria T. Potter
, Pramila Krishnamurthy
, et al.
·
Transplantation and Cellular Therapy
·
27
PDF
Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS
2011
·
Lingyun Wu
, Xiao Li
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
24
Comparative Analysis of AML Classification Systems: Evaluating the WHO, ICC, and ELN Frameworks and Their Distinctions
2024
·
Huda Salman
·
Cancers
·
22
PDF
Moderate to Severe Marrow Fibrosis As a More Advanced Risk Factor for MDS and MDS-AML Patients With Excess of Blasts Receiving Allogeneic Hematopoietic Stem Cell Transplantation
2021
·
Jiali Wang
, Qianqian Wang
, et al.
·
Transplantation and Cellular Therapy
·
18
The iodine I-131 tositumomab therapeutic regimen: Summary of safety in 995 patients with relapsed/refractory low grade (LG) and transformed LG non-Hodgkin's lymphoma (NHL)
2004
·
S. A. Gregory
, J. P. Leonard
, et al.
·
Journal of Clinical Oncology
·
17
Enumeration of CD34+ blasts by immunohistochemistry in bone marrow biopsies from MDS patients may have significant impact on final WHO classification
2020
·
Leonie Saft
, Botond Timar
, et al.
·
Journal of Hematopathology
·
16
PDF
Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
2010
·
Yasuyoshi Morita
, Akihisa Kanamaru
, et al.
·
International Journal of Hematology
·
16
Incidence of second primary malignancies (SPM) after 6-years follow-up of continuous lenalidomide in first-line treatment of multiple myeloma (MM).
2011
·
A. C. Rossi
, T. M. Mark
, et al.
·
Journal of Clinical Oncology
·
15
Point Mutations in the AML1/RUNX1 Gene Associated with Myelodysplastic Syndrome
2005
·
Hironori Harada
, Yuka Harada
·
Critical Reviews in Eukaryotic Gene Expression
·
15
Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome
2024
·
Jan Christian Schroeder
, Lucas Mix
, et al.
·
Bone Marrow Transplantation
·
14
PDF
Regulatory Mutations in GATA2 Associated with Aplastic Anemia
2012
·
Danielle M. Townsley
, Amy Hsu
, et al.
·
Blood
·
14
A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage: A pilot study
1996
·
Shin-ichiro Kuriya
, Kazunori Murai
, et al.
·
Cancer
·
14
PDF
Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS
2006
·
Hironori Harada
, Yuka Harada
, et al.
·
Current Cancer Drug Targets
·
12
Secondary leukaemia characterised by monosomy 7 occurring post-autologous stem cell transplantation for AML
1998
·
KP Rege
, SL Janes
, et al.
·
Bone Marrow Transplantation
·
10
AML and MDS Classification According to Who 2022 and International Consensus Classification: Do We Invent a Babylonian Confusion of Languages?
2022
·
Sandra Huber
, Constance Baer
, et al.
·
Blood
·
9
Show more works
View as search
Works count:
111
Citation count:
1,152
Year
Topic
Type